PharmExec Direct: Having trouble viewing the email? CLICK HERE

April 14/2015

Top Feature

Compliance at the Cross-Border Crossroads

Increasing demands for transparency have seen the role of chief compliance officer (CCO) evolve rapidly over the last 10 years. But the upcoming shift to cross-border compliance in Europe will present CCOs with their biggest challenge yet...
/Read more/
Europe

Putting Off Off-Label Decisions

When in doubt, commission a study. This well-known tactic has come to the rescue of the European Union once again in the face of renewed controversy over off-label prescribing of medicines. It's a perfect excuse for the EU to do nothing in the interim about off-label prescribing, writes Reflector ... /Read more/
Asia

Cautious Optimism for Indian Pharma

Over the past few years, Indian pharmaceutical companies have been attempting to re-orientate their efforts toward developing new innovative medicines. While this transition by generic-drug makers will remain slow, local companies are making headway in this sector, writes Jan Wan ... /Read more/
Advertorial

So What is Pharma's Ideal Role in Social?

Patients and Healthcare Professionals (HCPs) are active on social media and closed community forums, but Pharma is relatively inactive. But with social media conversations undoubtedly influencing patients and physicians, what role should pharma take in the conversation? ... /Read more/
US

Biosimilars in the US: Five Key Commercial Considerations

The US FDA's landmark approval last month of Novartis' Zarxio means biosimilars have arrived on U.S. shores. Companies entering this blossoming market should now be turning even greater attention to commercialization, says Rohit Sood. Here, he outlines five critical factors for companies entering the biosimilars market ...
/Read more/
UK

The NHS's Meningitis B Vaccine Deal

That the UK's National Health Service has struck a deal for a national roll-out of Bexsero, GSK's vaccine for Meningitis B in infants, is good but the NHS needs to do things like this better and faster, writes Leela Barham ... /Read more/
Leadership

Pharm Exec's Emerging Pharma Leaders 2015: Nominate Now!

It's time for you to tell us who you think should receive Pharm Exec's 2015 Emerging Pharma Leadership Award. Read more for details of how to nominate a colleague — or yourself ... /Read more/

industry update

Takeda Pharmaceutical Company Limited and Takeda's wholly owned subsidiary, Takeda Pharmaceuticals U.S.A. (TPUSA) announced that Ramona Sequeira will join TPUSA as President of the United States (US) Business Unit. In this role, Sequeira will lead all business operations for the US, and will report to Christophe Weber, Takeda’s President & Chief Executive Officer.
Atlantic Healthcare (Cambridge, UK) announced that Dr Lorin K. Johnson has been appointed to the Board of Directors.
Horizon Pharma (Dublin, Ireland) named Geoffrey M. Curtis as Group Vice President, Corporate Communications.
Metabolium (Romainville, France) appointed Dr. Khadidja Romari as Chief Operating Officer and Chief Scientific Director.
Vetter (Ravensburg, Germany) announced that the company’s Advisory Board unanimously appointed Oliver Albrecht as Managing Director effective April 1, 2015.
/ US FDA Steps Up Foreign Inspections/

/ Personalized Medicine at a Crossroads/

/ The Goods and Services Tax: Bane or Boon for Indian Pharma?/